Disclosed are methods for the treatment of diabetes by administering a composition comprising a pharmaceutically acceptable amount of a dual inhibitor of both 5-lipoxygenase (5-LO) and 12/15-lipoxygenase (12/15-LO) enzymes or of both 5-lipoxygenase (5-LO) and 15-lipoxygenase (15-LO) enzymes. The invention is also directed to methods of controlling blood glucose level in diabetic patients with a dual inhibitor of both 5-lipoxygenase (5-LO) and 12/15-lipoxygenase (12/15-LO) enzymes or of both 5-lipoxygenase (5-LO) and 15-lipoxygenase (15-LO) enzymes.
申请公布号
WO2006044556(A2)
申请公布日期
2006.04.27
申请号
WO2005US36853
申请日期
2005.10.13
申请人
GALILEO PHARMACEUTICALS, INC.;BODDUPALLI, SEKHAR;LIEBOWITZ, DAVID N.;MILLER, GUY
发明人
BODDUPALLI, SEKHAR;LIEBOWITZ, DAVID N.;MILLER, GUY